Power Law company profile

NRx Pharmaceuticals

Biotech & Life Sciences · Haifa, Israel · Founded 2014 Unicorn

Clinical-stage pharmaceutical company for mental health diseases

Valuation

$92M

Market cap · May/2026

Revenue

$1.2M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where NRx Pharmaceuticals has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States76.2%

🇨🇦 Canada11.9%

🇮🇱 Israel11.9%

3 countries shown

Web traffic by country

8.3K monthly visits
across markets

🇺🇸 United States45.8%

🇬🇧 United Kingdom22.9%

🇮🇳 India19.3%

🇯🇵 Japan4.8%

🇩🇪 Germany4.8%

Top 5 markets shown

Patent intelligence

$300k patent portfolio · 1 active families

Estimated portfolio value

$300k

0.33% of market cap · 621.3× smaller than top peer Quantum-Si ($186M)

1 active patent families

Where NRx Pharmaceuticals innovates Drug side effectsAnxietyDepressed - symptomSide effectAntipsychotic Medications

Where NRx Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across NRx Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about NRx Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about NRx Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NRx Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles